Sjogren's Syndrome and Clinical Benefits of Low-Dose Naltrexone Therapy: Additional Case Reports

Cureus
July 2020
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398709/

Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels

Arthritis Rheum
February 2013
https://pubmed.ncbi.nlm.nih.gov/23359310/​​​​​​​

 

Sarah Zielsdorf, MD, MS - Beyond Tired: CFS/ME or Not? (2017 Conference) (LDN, low dose naltrexone)

Dr Zielsdorf shares case studies of patients with CFS and ME and goes into the evidence showing that the hallmark of CFS/ME is a mitochondrial dysfunction and intense diet, nutritional antioxidant and other lifestyle modifications are the primary therapy for this disorder. 

 

Laurie Marzell, ND - LDN Case Studies (2017 Conference) (LDN, low dose naltrexone)

Raven from the US Crohn’s Disease, MS, Spondylitis and Lyme Disease (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Raven and from the United States has been diagnosed with Crohn's Disease, Multiple Sclerosis, Spondylitis, and Lymes Disease.